AKT1 and non-small cell lung carcinoma: LMO4 possesses the ability to promote tumor cell migration and invasion in non-small-cell lung cancer via the involvement of the protein kinase B/phosphatidylinositol 3-kinase (AKT/PI3K) signaling pathway (17).